Follow us on:
Breaking News
August 3, 2026
Breaking News
Breaking News
ContractPharma_Conference_2026_650x90
Editor's Pick
Lifecore_BrandedContent_0726_FeaturedSpotlight

Curium, Lantheus to Merge in Deal Worth Up to $8B

 
Curium, Lantheus to Merge in Deal Worth Up to $8B

The combined radiopharmaceutical company will span diagnostics and therapeutics, and serve patients in more than 70 countries.
Read More >>

Headlines

Breaking News

Codis Completes Acquisition of Catalent’s Nottingham, UK Facility

Expands spray dry offering in Europe with oral solid dose development and small‑scale commercial manufacturing.

SPONSOR

How Manufacturers Are Addressing Today’s Sterile Injectable Challenges

This eBook covers contamination control, aseptic manufacturing, compliance strategies, and planning considerations for complex injectable products.

Breaking News

AdvanCell Breaks Ground on New U.S. Headquarters & Flagship Manufacturing Facility

The 128,000-square-foot facility will strengthen the company's global manufacturing capabilities for next-generation targeted alpha therapies.

Breaking News

BioNTech Names Guido Oelkers as CEO

Will succeed co-founders and executives, Ugur Sahin, Chief Executive Officer, and ⁠ Oezlem Tuereci, Chief Medical Officer from February 1, 2027.

SPONSOR

Flexibility in Drug Development: From Tactical Response to Strategic Discipline

How strategic flexibility enables continuity, scalability, and reliable execution in modern drug development.

AAPS_CP_Box Ad_0826

Breaking News
Trials & Filings

FDA Clears Ractigen IND Application for Novel saRNA Candidate in Proliferative Vitreoretinopathy

The FDA milestone follows a similar IND approval in China in March 2025.

Featured Resources

Solution Content Center SPOTLIGHT

Sentry BioPharma Services, Inc.

Sentry BioPharma Services, Inc. (Sentry US) protects product SISPQ by offering compliant pharmaceutical services, including cGMP temperature-controlled storage, controlled substance management (CS III-V), clinical/commercial labeling and secondary packaging. Sentry also provides import/export optimization by leveraging our end-to-end GxP logistics, global distribution and Foreign Trade Zone expertise. Sentry’s status as a US Foreign Trade Zone enables products from outside the United States to be received and held within cGMP storage, pending approval for importation from the FDA, CBP and DEA. Sentry is VAWD accredited, licensed in all US states and inspected by the FDA, along with numerous international authorities. Sentry’s newest facility in Columbus, IN provides stock splitting risk mitigation services and will offer additional cGMP offerings in 2026.

 

Solution Center SPOTLIGHT

Almac Group

Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution.